Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 therapeutics: Challenges and directions for the future
Philip C. Robinson, David Liew, Helen Tanner, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 15
Open Access | Times Cited: 142

Showing 1-25 of 142 citing articles:

The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics
Linghui Qian, Xuefen Lin, Xue Gao, et al.
Chemical Reviews (2023) Vol. 123, Iss. 12, pp. 7782-7853
Closed Access | Times Cited: 64
Optimized SARS-CoV-2 Spike Protein Detection via Coupling Coefficient-Driven Fast Fourier Transform Analysis in a Peptide-Functionalized Fiber Optic Biosensor.
Oskar Arrizabalaga, Alana Thais Gisch Andres, José L. Zugaza, et al.
Sensors and Actuators B Chemical (2025) Vol. 428, pp. 137226-137226
Open Access | Times Cited: 1
The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications
Douglas B. Kell, Etheresia Pretorius
Biochemical Journal (2022) Vol. 479, Iss. 16, pp. 1653-1708
Open Access | Times Cited: 52
Fungal Infection in Co-infected Patients With COVID-19: An Overview of Case Reports/Case Series and Systematic Review
Sima Sadat Seyedjavadi, Parmida Bagheri, Mohammad Javad Nasiri, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 39
Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19
Federico Baldi, Chiara Dentone, Małgorzata Mikulska, et al.
Frontiers in Medicine (2023) Vol. 9
Open Access | Times Cited: 29
Antiviral Molecular Targets of Essential Oils against SARS-CoV-2: A Systematic Review
Muhammad Iqhrammullah, Diva Rayyan Rizki, Agnia Purnama, et al.
Scientia Pharmaceutica (2023) Vol. 91, Iss. 1, pp. 15-15
Open Access | Times Cited: 24
Recent Trends in Lateral Flow Immunoassays with Optical Nanoparticles
Jaehi Kim, Minsup Shin, Jonghyun Shin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9600-9600
Open Access | Times Cited: 24
Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19
Bibo Zhu, Xiaoqin Wei, Harish Narasimhan, et al.
Science Immunology (2023) Vol. 8, Iss. 82
Open Access | Times Cited: 23
After the Hurricane: Anti-COVID-19 Drugs Development, Molecular Mechanisms of Action and Future Perspectives
Hazim O. Khalifa, Yousef Al Ramahi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 739-739
Open Access | Times Cited: 10
Cardiac tissue model of immune-induced dysfunction reveals the role of free mitochondrial DNA and the therapeutic effects of exosomes
Rick Xing Ze Lu, Naimeh Rafatian, Yimu Zhao, et al.
Science Advances (2024) Vol. 10, Iss. 13
Open Access | Times Cited: 9
Antiviral fibrils of self-assembled peptides with tunable compositions
Joseph Dodd‐o, Abhishek Roy, Zain Siddiqui, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics
Yash Gupta, Oleksandr V. Savytskyi, Matt Coban, et al.
Molecular Aspects of Medicine (2022) Vol. 91, pp. 101151-101151
Open Access | Times Cited: 30
Analysis of Antiviral Drug Usage in COVID-19 Fatalities: A Retrospective Study
Mohamed Hassan Dehghan, Mahdis Parhizgar, Delaram Fadaee Heydarabadi, et al.
Deleted Journal (2025) Vol. 2, Iss. 1
Open Access
Second booster doses of adenoviral- and mRNA-based COVID-19 vaccines increase protection against COVID-19 hospitalization: Final analysis from the REFORCO-Brazil real-world effectiveness study during Omicron
Wilhelmine Meeraus, Abigail Postema, Christen Gray, et al.
Vaccine (2025) Vol. 53, pp. 126955-126955
Open Access
Airway Epithelial Cell Junctions as Targets for Pathogens and Antimicrobial Therapy
Nannan Gao, Fariba Rezaee
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2619-2619
Open Access | Times Cited: 22
Single-Molecule Analysis of SARS-CoV-2 Binding to C-Type Lectin Receptors
Joshua D. Simpson, Ankita Ray, C. Marcon, et al.
Nano Letters (2023) Vol. 23, Iss. 4, pp. 1496-1504
Closed Access | Times Cited: 14
Red Blood Cell-Derived Extracellular Vesicles Display Endogenous Antiviral Effects and Enhance the Efficacy of Antiviral Oligonucleotide Therapy
Migara Kavishka Jayasinghe, Chang Gao, Gracemary Yap, et al.
ACS Nano (2023) Vol. 17, Iss. 21, pp. 21639-21661
Open Access | Times Cited: 12
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)
William HK Schilling, Podjanee Jittamala, James A Watson, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 11
Computational screening of potential bromodomain-containing protein 2 inhibitors for blocking SARS-CoV-2 infection through pharmacophore modeling, molecular docking and molecular dynamics simulation
Shaohua Xu, Huicheng Yuan, Ling Li, et al.
Arabian Journal of Chemistry (2023) Vol. 17, Iss. 1, pp. 105365-105365
Open Access | Times Cited: 11
From Emergence to Endemicity: A Comprehensive Review of COVID-19
Roopa Naik, Sreekant Avula, Sujith K Palleti, et al.
Cureus (2023)
Open Access | Times Cited: 11
Identification of a short ACE2-derived stapled peptide targeting the SARS-CoV-2 spike protein
Lorenzo Calugi, Giulia Sautariello, Elena Lenci, et al.
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115118-115118
Open Access | Times Cited: 10
In silico screening of phenylethanoid glycosides, a class of pharmacologically active compounds as natural inhibitors of SARS-CoV-2 proteases
Caio Cheohen, Maria Eduarda Alves Esteves, Thamirys Silva da Fonseca, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 1461-1472
Open Access | Times Cited: 10
Lung tropism in hospitalized patients following infection with SARS-CoV-2 variants from D614G to Omicron BA.2
Yosuke Hirotsu, Yumiko Kakizaki, Akitoshi Saito, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 10
Ovatodiolide inhibits SARS-CoV-2 replication and ameliorates pulmonary fibrosis through suppression of the TGF-β/TβRs signaling pathway
Wei-Chung Chiou, Guan‐Jhong Huang, Tein‐Yao Chang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114481-114481
Open Access | Times Cited: 10
Inflammasomes during SARS-CoV-2 infection and development of their corresponding inhibitors
Rominah Onintsoa Diarimalala, Yanhong Wei, Da Hu, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top